Industrial Strength Bio Seminar Series
Featuring leaders from the bioscience industry, the Industrial Strength Bio Seminar Series provides insights about companies and glimpses of developments in fields such as protein research, competitive intelligence, microfluidics engineering, commercialization and much more.
2011-2012 Seminars
September 6, 2011
Carl Garner and Jamie Dananberg
Eli Lilly & Co.
Leadership in Project Management
September 23, 2011
Laura L Mays Hoopes, PhD
Professor of Biology & Molecular Biology, Pomona College
Fountain of Youth for Budding Yeast
September 29, 2011
Eric McAfee
Chairman of McAfee Capital
Entrepreneurship and the State of the Biofuels Industry
October 13, 2011
Brent Erickson
Executive Vice President, Industrial and Environmental Section, Biotechnology Industry Organization
15 Ways Biotech is Greening Our Pantries
October 21, 2011
Geoffrey Schwartz
Director Strategic Marketing Communications, EMD Millipore Bioscience Division
Marketing Communications in Today's Life Science World
November 8, 2011
Gregory Milman, PhD
Director, NIAID Office of Innovation National Institutes of Health
Tapping Into $700 Million in NIH Small Business Funds
November 16, 2011
David Watumull
Co-founder, President & CEO, Cardax Pharmaceuticals
Cardax: proprietary prodrug development in Hawaii
January 24, 2012
Frank Jing
Sales Engineer, Fogale Biotech Inc.
The Mouse that swallowed the Elephant: how Fogale Plans to Change the Bioprocess Development Space
January 25, 2012
Myles Marcus
Vice President, Supply Chain Management, Dendreon Inc.
The Dendreon Story
January 26, 2012
Harvey Yau
Science Product Manager, Americas Region, Kelly Services
Life Science Workforce and Outsource Models
February 6, 2012
Alan Miller, MD, PhD
Chief of Oncology, Baylor University Medical Center at Dallas
Clinical Trials: Why we do them. What we have learned
February 15, 2012
Speakers from Christie, Parker & Hale, LLC
Introduction to Patents in Biotechnology
February 20, 2012
Mark Groudas
Vice President of Waters Inc.
The Waters Story